These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1447707)

  • 1. A semiempirical computational investigation of the antipsoriatic drug anthralin.
    Holder AJ; Upadrashta SM
    J Pharm Sci; 1992 Nov; 81(11):1074-8. PubMed ID: 1447707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals.
    Müller K
    Biochem Pharmacol; 1997 May; 53(9):1215-21. PubMed ID: 9214681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure specificity of the antipsoriatic anthrones.
    Krebs A; Schaltegger H; Schaltegger A
    Br J Dermatol; 1981 Aug; 105 Suppl 20():6-11. PubMed ID: 7284267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsoriatic drug action of anthralin: oxidation reactions with peroxidizing lipids.
    Ducret F; Lambelet P; Löliger J; Savoy MC
    J Free Radic Biol Med; 1985; 1(4):301-6. PubMed ID: 3836247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prototropy, Intramolecular Interactions, Electron Delocalization, and Physicochemical Properties of 1,8-dihydroxy-9-anthrone-DFT-D3 Study of Substituent Effects.
    Szymańska M; Majerz I
    Molecules; 2023 Jan; 28(1):. PubMed ID: 36615539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis.
    Müller K; Huang HS; Wiegrebe W
    J Med Chem; 1996 Aug; 39(16):3132-8. PubMed ID: 8759634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. Modifications of short-contact therapy and Ingram therapy.
    Schulze HJ; Schauder S; Mahrle G; Steigleder GK
    J Am Acad Dermatol; 1987 Jul; 17(1):19-24. PubMed ID: 3611453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antipsoriatic effect of dithranol (anthralin). 2].
    Raab W
    Hautarzt; 1975 Sep; 26(9):456-9. PubMed ID: 1102494
    [No Abstract]   [Full Text] [Related]  

  • 9. Anthralin-derived transients--II. Formation of the radical by spontaneous fragmentation of both singlet and triplet states of the 10,10'-dehydrodimer: radical pair multiplicity effects.
    Bruce JM; Dodd NJ; Gorman AA; Hamblett I; Kerr CW; Lambert C; McNeeney SP
    Photochem Photobiol; 1990 Aug; 52(2):345-51. PubMed ID: 2217548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantitation of 1,8,9-anthracenetriol, 1,8-dihydroxy-9,10-anthraquinone, and 1,8,1',8'-tetrahydroxy-10,10'-dianthrone by reversed-phase high-performance liquid chromatography.
    Wurster DE; Upadrashta SM
    J Chromatogr; 1986 Jul; 362(1):71-8. PubMed ID: 3745364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antipsoriatic effect of dithranol (anthralin). 1].
    Raab W
    Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyl radical damage to DNA sugar and model membranes induced by anthralin (dithranol).
    Müller K; Gürster D
    Biochem Pharmacol; 1993 Nov; 46(10):1695-704. PubMed ID: 8250955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irritation, staining and antipsoriatic activity of 10-acyl analogues of anthralin.
    Mustakallio KK
    Br J Dermatol; 1981 Aug; 105 Suppl 20():23-7. PubMed ID: 6169361
    [No Abstract]   [Full Text] [Related]  

  • 15. The antipsoriatic drug, anthralin, inhibits protein kinase C--implications for its mechanism of action.
    Hegemann L; Fruchtmann R; van Rooijen LA; Müller-Peddinghaus R; Mahrle G
    Arch Dermatol Res; 1992; 284(3):179-83. PubMed ID: 1503504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence remission spectroscopy of psoriatic lesions and the effect of topical anthralin therapy.
    Wollina U; Schmidt WD; Koch A; Scheibe A; Erfurth F; Fassler D
    J Eur Acad Dermatol Venereol; 2009 Dec; 23(12):1409-13. PubMed ID: 19508501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dithranol].
    Melhorn S
    Hautarzt; 2017 May; 68(5):421-423. PubMed ID: 28401270
    [No Abstract]   [Full Text] [Related]  

  • 18. Anthralin cream as short contact therapy for psoriasis.
    Miller AC
    Cutis; 1985 Jun; 35(6):578-82. PubMed ID: 4017653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anthralin therapy of psoriasis--a retrospective study of 39 cases].
    Higashi K; Katayama I; Nishioka K; Nishiyama S
    Nihon Hifuka Gakkai Zasshi; 1989 Feb; 99(2):129-34. PubMed ID: 2746967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenone derivatives by mass spectrometry.
    Huang HS; Lin PY
    Proc Natl Sci Counc Repub China B; 2000 Jan; 24(1):20-5. PubMed ID: 10786935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.